SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (7418)1/5/2000 12:55:00 PM
From: JMarcus  Read Replies (1) | Respond to of 9719
 
Does anyone here follow CORX? I've been holding it as a long term investment, patiently waiting for it to make a move. It is up 24% to $.95, which is the highest it has been since August. No news that I can see.

Marc



To: scaram(o)uche who wrote (7418)1/5/2000 9:19:00 PM
From: michael_f_murphy  Read Replies (2) | Respond to of 9719
 
re: LSE:CAT David Chiswell

The CEO of LSE:CAT David Chiswell (age 45) has UCLA department of Immunology and Microbiology on his CV.
Do you know or know of him?



To: scaram(o)uche who wrote (7418)1/6/2000 3:19:00 PM
From: michael_f_murphy  Respond to of 9719
 
>> patent positions

A beginning on LSE:CAT patents is at
Message 12487266

Has some abstracts for some LSE:CAT patents (US, EP and WO)but no analysis or comparison to competitors. Most are related to antibody production using phage display technology. A few relate specifically to drugs in test.

Did this before getting hints and tips from George.